The VELA Mammography Chair is the latest and most significant development in women's imaging in the U.S. TAMPA, FL /...
Beauty-Stem Biomedical continues to make strides in preventive medicine, advancing the science of stem cell nutrition to prevent and combat...
WILMINGTON, Del., Oct. 30, 2024 /PRNewswire/ -- Geneyx Inc. a pioneering global company for an AI Multi-Omics analysis system, and Ocean...
Helix reveals new research developments in a wide range of therapeutic areas at the American Society of Human Genetics 2024...
Life sciences, academic medical centers, health systems, and research institutes can gain insights into diseases and their impact on patients...
STOCKHOLM, SE / ACCESSWIRE / October 30, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical...
NEW YORK, Oct. 29, 2024 /PRNewswire/ -- Report with market evolution powered by AI - The global sperm separation devices...
North Bergen, New Jersey--(Newsfile Corp. - October 29, 2024) - Apollo Biowellness, Inc. (OTC Pink: KOAN) - Evolutionary Biologics is...
Industry Leader to Drive Adoption of Breakthrough Blood-Based Technology and Fragmentomics Platform for Improved Screening and Monitoring BALTIMORE and PALO...
Pieces will deploy new conversational AI at MetroHealth that will interact directly with cancer patients and leverage pioneering human oversight...
It is estimated that 10-15% of people in the United States have IBS SAN FRANCISCO, CA / ACCESSWIRE / October...
Leading podiatrists renew their commitment to public health and community involvement, championing the annual cancer event for the past 22...
SEATTLE WA AND LUND, SWEDEN / ACCESSWIRE / October 29, 2024 / Aptevo Therapeutics ("Aptevo") (NASDAQ:APVO) and Alligator Bioscience AB...
RMAT Designation Follows Positive Proof-of-Concept Data from the ALLO-316 TRAVERSE Trial in Adult Patients with Advanced or Metastatic CD70 Positive...
Newly analyzed biomarker data from the initial dose-escalation Phase 1 AD trial found that troculeucel reduces GFAP, NfL, p-tau181, GDF-15,...
CHATHAM, N.J., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated...
Positive feedback received from US FDA regarding the planned TACTI-004 Phase III in first-line non-small cell lung cancer successfully concluding...
Significantly expands scope of patent coverage for Company’s proprietary drug delivery systems to now include transdermal deliveryPatent expected to issue...
NORWOOD, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced...
CHICAGO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Pathos AI, a clinical-stage biotechnology company focused on re-engineering drug development through artificial...